{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:00:59Z","timestamp":1792879259282,"version":"4.5.0"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227104","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T18:07:20Z","timestamp":1578506840000},"page":"e0227104","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":59,"title":["Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1476-9892","authenticated-orcid":true,"given":"Steven S.","family":"Good","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Pietropaolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Sommadossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"pone.0227104.ref001","unstructured":"Hepatitis C Fact Sheet. World Health Organization 2019 [updated Jul 9, 2019. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c.]"},{"key":"pone.0227104.ref002","unstructured":"AASLD-IDSA. Recommendations for Testing, Managing, and Treating Hepatitis C 2019 [updated Nov 6, 2019. Available from: https:\/\/www.hcvguidelines.org\/evaluate\/testing-and-linkage.]"},{"issue":"1","key":"pone.0227104.ref003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/liv.13212","article-title":"Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection","volume":"37","author":"J Feld","year":"2017","journal-title":"Liver Int"},{"key":"pone.0227104.ref004","unstructured":"Hosein S. HCV treatment in advanced liver disease CATIE2018 [Available from: https:\/\/www.catie.ca\/en\/treatmentupdate\/treatmentupdate-227\/hepatitis-c-virus\/hcv-treatment-advanced-liver-disease.]"},{"issue":"49","key":"pone.0227104.ref005","doi-asserted-by":"crossref","first-page":"49164","DOI":"10.1074\/jbc.M305041200","article-title":"Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro","volume":"278","author":"G Migliaccio","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"pone.0227104.ref006","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hep.27488","article-title":"Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C","volume":"62","author":"T Ahmad","year":"2015","journal-title":"Hepatology"},{"key":"pone.0227104.ref007","volume-title":"Once-daily sofosbuvir plus ribavirin given for 12 or 24 weeks in treatment-naive patients with HCV infection: the QUANTUM study","author":"J Lalezari","year":"2013"},{"key":"pone.0227104.ref008","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/ml100209f","article-title":"Discovery of PSI-353661, a novel purine nucleotide prodrug for the treatment of HCV infection","volume":"2","author":"W Chang","year":"2011","journal-title":"ACS Med Chem Lett"},{"issue":"45","key":"pone.0227104.ref009","doi-asserted-by":"crossref","first-page":"34337","DOI":"10.1074\/jbc.M110.161802","article-title":"Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977","volume":"285","author":"E Murakami","year":"2010","journal-title":"J Biol Chem"},{"issue":"16","key":"pone.0227104.ref010","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1021\/jm200650j","article-title":"Adenosine deaminase-like protein 1 (ADAL1): characterization and substrate specificity in the hydrolysis of N(6)- or O(6)-substituted purine or 2-aminopurine nucleoside monophosphates","volume":"54","author":"E Murakami","year":"2011","journal-title":"J Med Chem"},{"issue":"11","key":"pone.0227104.ref011","doi-asserted-by":"crossref","first-page":"e1003030","DOI":"10.1371\/journal.ppat.1003030","article-title":"Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleolsides","volume":"8","author":"J Arnold","year":"2012","journal-title":"PLoS Pathog"},{"issue":"2","key":"pone.0227104.ref012","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1128\/AAC.01922-15","article-title":"Role of mitochondrial RNA polymerase in the toxicity of nucleotide inhibitors of hepatitis C virus","volume":"60","author":"J Feng","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"pone.0227104.ref013","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.antiviral.2011.05.003","article-title":"Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661","volume":"91","author":"P Furman","year":"2011","journal-title":"Antiviral Res"},{"issue":"7","key":"pone.0227104.ref014","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1128\/AAC.00530-12","article-title":"Metabolic activation of the anti-hepatitis C virus nucleotide prodrug PSI-352938","volume":"56","author":"C Niu","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pone.0227104.ref015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/mutage\/15.4.361","article-title":"Induction of apoptosis and inhibition of signalling pathways by alkylated purines","volume":"15","author":"S Bonatti","year":"2000","journal-title":"Mutagenesis"},{"issue":"2","key":"pone.0227104.ref016","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/187231209788654081","article-title":"Esterase activities in the blood, liver and intestine of several preclinical species and humans","volume":"3","author":"L Berry","year":"2009","journal-title":"Drug Metab Lett"},{"issue":"10","key":"pone.0227104.ref017","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1002\/jps.23258","article-title":"Species difference of esterase expression and hydrolase activity in plasma","volume":"101","author":"F Bahar","year":"2012","journal-title":"J Pharm Sci"},{"issue":"2","key":"pone.0227104.ref018","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hep.27488","article-title":"Cardiac dysfunction associated with a nucleotide polymerase inhibitor for threatment of hepatitis C","volume":"62","author":"T Ahmad","year":"2015","journal-title":"Hepatology"},{"key":"pone.0227104.ref019","doi-asserted-by":"crossref","first-page":"2040206618758524","DOI":"10.1177\/2040206618758524","article-title":"Addressing the selectivity and toxicity of antiviral nucleosides","volume":"26","author":"J Feng","year":"2018","journal-title":"Antivir Chem Chemother"},{"issue":"2","key":"pone.0227104.ref020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/mutage\/1.2.99","article-title":"Cytogenetic effects induced by alkylated guanine in mammalian cells","volume":"1","author":"S Bonatti","year":"1986","journal-title":"Mutagenesis"},{"issue":"2","key":"pone.0227104.ref021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/mutage\/10.2.105","article-title":"The induction of aneuploidy by alkylated purines: effects on early and late cell cycle events","volume":"10","author":"M Simili","year":"1995","journal-title":"Mutagenesis"},{"issue":"6","key":"pone.0227104.ref022","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.32.6.647","article-title":"Validated assays for human cytochrome P450 activities","volume":"32","author":"R Walsky","year":"2004","journal-title":"Drug Metab Dispos"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T18:07:44Z","timestamp":1578506864000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227104"}},"subtitle":[],"editor":[{"given":"Luis","family":"Men\u00e9ndez-Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227104","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,8]]}}}